[CLINICAL CASE: THE SIDE EFFECTS OF STATINS].

The clinical studies, conducted in recent years, suggest that statins increase the activity of telomerase and by that decelerate speed of telomerase shortening. Thus, on one hand, it reduces a risk of cardiovascular diseases development, decelerate aging, but on the other hand, increasing the activity of telomerase, lead to expression rising of gene hTERT, that can make prerequisites for malignancy. That's why, it's necessary to study the subject and develop reliable criteria for safety use of activators-telomerase.

[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].

Malaria is one of the most important and common infectious diseases in the world. The world health organization estimates 225 million malaria cases worldwide. Malaria is one of the strongest selective factors affecting the human genotype.

[SEVERE FORMS OF TROPICAL MALARIA: MOLECULAR GENETIC FEATURES OF THE COURSE OF THE INFECTION (REVIEW)].

The article overviews some issues of the severe course of tropical malaria. In addition to the analysis of the ongoing situation with malaria in Russia, a general clinical picture of the severe course of tropical malaria is discussed. The main part of the overview includes a detailed analysis of current data on the molecular genetic aspects of the erythrocytes' adhesion in the case of tropical malaria.

[THE SIGNIFICANCE OF THE SYSTEM APPROACH IN THE STUDY OF THE GENERAL ADAPTATION SYNDROME' REACTIONS].

The article discusses the problems of the process of environmental adaptations appearance which are based on the general principles of functional systems' constitution. The value of the theory of functional systems development as the basis for physiological cybernetics (P. Anokhin, 1935) is also given.

[COMPARISON OF THE EFFECTIVENESS OF DRUGS FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS IN VITRO].

In this study, we studied the activity of three antibacterial drugs: Cefotaxime (Claforan, France), Ceftriaxone (Russia) and Doxycycline (Russia). The control group is a pentavalent antimony drug - Glucantim (France), which has been the "gold standard" for a long time in the treatment of any form of leishmaniasis. During the experiments, the leading positions of doxycycline and ceftriaxone established in vitro.